fda warning letters compounded semaglutide tirzepatide september 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA and Novo Nordisk Warned

Can you adjust the dosage for better weight loss results

Each has advantages depending on your situation, insurance coverage, and personal preferences

For researchers evaluating whether to commit to retatrutide protocols now, the relevant comparison isnt just against existing dual agonistsits against the 2436 month pipeline of next-generation metabolic peptides that may offer superior efficacy at comparable or lower cost

The need for ongoing monitoring and the risk of serious adverse events can make these medications a less appealing option for the long-term management of diabetes and obesity-related heart issues

Medications will only be prescribed after a comprehensive review and professional evaluation by our team